|
Market Closed -
Nasdaq Stockholm
08:30:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 2.270 SEK | +6.57% |
|
+14.65% | +19.47% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 52.44M | - | - | - | - | - |
| 1,224B | |||||
| 662B | |||||
| 514B | |||||
| 388B | |||||
| 361B |
- Stock Market
- Stocks
- ENZY Stock
- Charts Enzymatica AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
